TY - JOUR
T1 - Five-year decline in estimated glomerular filtration rate associated with a higher risk of renal disease and atherosclerotic vascular disease clinical events in elderly women
AU - Lim, Wai
AU - Lewis, Joshua
AU - Wong, G.
AU - Dogra, G.K.
AU - Zhu, Kun
AU - Lim, E.M.
AU - Dhaliwal, S.S.
AU - Prince, Richard
PY - 2013
Y1 - 2013
N2 - Background: Estimated glomerular filtration rate (eGFR) has been demonstrated to predict atherosclerotic vascular disease (ASVD)-associated clinical events independent of traditional vascular risk factors. Recent studies have demonstrated that eGFR decline over time may improve prediction of ASVD-associated mortality risk in chronic kidney disease (CKD) patients.Aim: The aim of this study is to evaluate the association between 5-year change in eGFR with renal disease and ASVD-associated clinical events.Design: Prospective observational study.Methods: A total of 1012 women over the age of 70 years from the Calcium Intake Fracture Outcome Study were included. Baseline characteristics including baseline and 5-year creatinine, participants’ comorbidities and complete verified 10-year records for ASVD and renal disease-associated hospitalization and/or mortality were obtained using the Western Australian Data Linkage System.Results: Participants were stratified according to annual rate of eGFR change in quartiles [≤−1.2 (first quartile), >−1.2 to 0.1 (second quartile), >0.1–1.7 (third quartile) and >1.7 ml/min/1.73 m2/year (fourth quartile)]. In the adjusted model, compared with participants in the fourth quartile, those in the first and/or second quartiles of annual eGFR change had significantly higher risk of renal disease and/or ASVD-associated clinical events. However, the association with renal clinical events was more pparent in participants with baseline eGFR of
AB - Background: Estimated glomerular filtration rate (eGFR) has been demonstrated to predict atherosclerotic vascular disease (ASVD)-associated clinical events independent of traditional vascular risk factors. Recent studies have demonstrated that eGFR decline over time may improve prediction of ASVD-associated mortality risk in chronic kidney disease (CKD) patients.Aim: The aim of this study is to evaluate the association between 5-year change in eGFR with renal disease and ASVD-associated clinical events.Design: Prospective observational study.Methods: A total of 1012 women over the age of 70 years from the Calcium Intake Fracture Outcome Study were included. Baseline characteristics including baseline and 5-year creatinine, participants’ comorbidities and complete verified 10-year records for ASVD and renal disease-associated hospitalization and/or mortality were obtained using the Western Australian Data Linkage System.Results: Participants were stratified according to annual rate of eGFR change in quartiles [≤−1.2 (first quartile), >−1.2 to 0.1 (second quartile), >0.1–1.7 (third quartile) and >1.7 ml/min/1.73 m2/year (fourth quartile)]. In the adjusted model, compared with participants in the fourth quartile, those in the first and/or second quartiles of annual eGFR change had significantly higher risk of renal disease and/or ASVD-associated clinical events. However, the association with renal clinical events was more pparent in participants with baseline eGFR of
U2 - 10.1093/qjmed/hct043
DO - 10.1093/qjmed/hct043
M3 - Article
C2 - 23407347
VL - 106
SP - 443
EP - 450
JO - Q J M : an international journal of medicine
JF - Q J M : an international journal of medicine
SN - 1460-2393
IS - 5
ER -